InDex Pharmaceuticals Updates Shareholders List
STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019.
The 10 largest shareholders in InDex Pharmaceuticals Holding AB (publ) were per August 30, 2019 of:
Shareholder Number of shares Ownership % Votes %
---
14 657 241 21.3 21.3
SEB Venture Capital
---
12 900 272 18.8 18.8
Stiftelsen Industrifonden
---
3 124 718 4.5 4.5
Staffan Rasjö
---
2 918 719 4.2 4.2
Avanza Pension
---
2 908 298 4.2 4.2
Linc AB
---
1 785 714 2.6 2.6
SEB Stiftelsen
---
1 454 150 2.1 2.1
SEB Life International
---
1 217 201 1.7 1.7
NeoMed/N5
---
1 181 676 1.7 1.7
Nordnet Pension
---
980 081 1.4 1.4
Rune Pettersson
---
973 996 1.4 1.4
Ponderus Invest AB
---
For more information:
Peter Zerhouni, CEO
Phone: +46-8-508-847-35
E-mail: peter.zerhouni@indexpharma.com
InDex Pharmaceuticals in brief
InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The company's lead asset is the drug candidate cobitolimod, which is in late stage clinical development for the treatment of moderate to severe ulcerative colitis - a debilitating, chronic inflammation of the large intestine. InDex has also developed a platform of patent protected discovery stage substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in treatment of various immunological diseases.
InDex is based in Stockholm, Sweden. The company's shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm. Redeye AB with e-mail certifiedadviser@redeye.se and phone number +46-8-121-576-90 is the company's Certified Adviser. For more information, please visit www.indexpharma.com
Publication
This information is information that InDex Pharmaceuticals Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication through the agency of the contact person set out above at 08:45 CET on September 5, 2019.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Main/9612/2896518/1100874.pdf PR InDex updates shareholders
list
View original content:http://www.prnewswire.com/news-releases/index-pharmaceuticals-updates-shareholders-list-300912321.html
SOURCE InDex Pharmaceuticals
